Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.

Naganuma M, Sugimoto S, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Suda W, Hattori M, Fukuda S, Hirayama A, Abe T, Watanabe M, Hibi T, Suzuki Y, Kanai T; INDIGO Study Group.

Gastroenterology. 2018 Mar;154(4):935-947. doi: 10.1053/j.gastro.2017.11.024. Epub 2017 Nov 22.

PMID:
29174928
2.

Anticipated discrimination among people with schizophrenia.

U├žok A, Brohan E, Rose D, Sartorius N, Leese M, Yoon CK, Plooy A, Ertekin BA, Milev R, Thornicroft G; INDIGO Study Group.

Acta Psychiatr Scand. 2012 Jan;125(1):77-83. doi: 10.1111/j.1600-0447.2011.01772.x. Epub 2011 Oct 24.

PMID:
22017644
3.

Reported stigma and discrimination by people with a diagnosis of schizophrenia.

Rose D, Willis R, Brohan E, Sartorius N, Villares C, Wahlbeck K, Thornicroft G; INDIGO Study Group.

Epidemiol Psychiatr Sci. 2011 Jun;20(2):193-204. Erratum in: Epidemiol Psychiatr Sci. 2011 Dec;20(4):379.

PMID:
21714366
4.

Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey.

Thornicroft G, Brohan E, Rose D, Sartorius N, Leese M; INDIGO Study Group.

Lancet. 2009 Jan 31;373(9661):408-15. doi: 10.1016/S0140-6736(08)61817-6. Epub 2009 Jan 21.

PMID:
19162314

Supplemental Content

Loading ...
Support Center